Suppr超能文献

小型听神经瘤同期行人工耳蜗植入与早期内镜手术

Simultaneous cochlear implantation with early endoscopic surgery in small acoustic neuroma.

作者信息

Bae Seong Hoon, Battilocchi Ludovica, Yunbin Nam, Lapina Gerard, Yun Ji Min, Moon In Seok

机构信息

Department of Otorhinolaryngology Gangnam Severance Hospital, Yonsei University College of Medicine Seoul South Korea.

Department of Otolaryngology and Head and Neck Surgery Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.

出版信息

Laryngoscope Investig Otolaryngol. 2024 Aug 21;9(4):e1319. doi: 10.1002/lio2.1319. eCollection 2024 Aug.

Abstract

OBJECTIVES

The exclusive endoscopic transcanal transpromontorial approach (EETTA) has recently been developed for the removal of small-sized acoustic neuromas in the labyrinth (intralabyrinthine schwannoma [ILS]) or internal auditory canal (IAC). Although small tumors that meet the indications for EETTA are also good candidates for cochlear implantation (CI), there are few reports on CI after schwannoma removal using EETTA. Here we present an outcome of patients who underwent simultaneous EETTA and CI.

METHODS

Five patients (two with IAC fundus tumors and three with ILS) who underwent simultaneous EETTA and CI between 2020 and 2022 were retrospectively enrolled. Their medical charts and test results were reviewed.

RESULTS

After at least 12 months of follow-up, there were no severe surgical complications such as meningitis, infection, or skin necrosis. Four of the five patients responded to auditory stimulation. Three out of four auditory-responsive patients scored >80% on sentence recognition.

CONCLUSION

Simultaneous EETTA and CI are feasible for the treatment of ILS and IAC fundus tumors. Preservation of the cochlear nerve and modiolus is important for favorable CI outcomes. Therefore, ILS and IAC fundus tumors in patients with nonserviceable hearing should be surgically removed as early as possible to enable proper hearing rehabilitation with CI.

LEVEL OF EVIDENCE

Level 4.

摘要

目的

最近开发了一种独特的内镜经耳道经岬入路(EETTA),用于切除迷路内(迷路内神经鞘瘤[ILS])或内耳道(IAC)的小型听神经瘤。虽然符合EETTA适应证的小肿瘤也是人工耳蜗植入(CI)的良好候选者,但关于使用EETTA切除神经鞘瘤后进行CI的报道很少。在此,我们报告了接受EETTA和CI联合手术的患者的治疗结果。

方法

回顾性纳入了2020年至2022年间接受EETTA和CI联合手术的5例患者(2例为IAC底肿瘤,3例为ILS)。对他们的病历和检查结果进行了回顾。

结果

经过至少12个月的随访,未出现严重的手术并发症,如脑膜炎、感染或皮肤坏死。5例患者中有4例对听觉刺激有反应。4例有听觉反应的患者中有3例在句子识别测试中得分>80%。

结论

EETTA和CI联合手术治疗ILS和IAC底肿瘤是可行的。保留蜗神经和蜗轴对获得良好的CI效果很重要。因此,对于听力丧失的患者,应尽早手术切除ILS和IAC底肿瘤,以便通过CI进行适当的听力康复。

证据水平

4级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4465/11337909/627296d73ead/LIO2-9-e1319-g002.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验